Get started
GH Research PLCGH Research PLCGH Research PLC

GH Research PLC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GHRS chart


Full chart

GHRS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪873.98 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.80 USD
Net income (FY)
‪−35.59 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪30.44 M‬
Beta (1Y)
0.62

Employees


Employees (FY)
49
Change (1Y)
+17 +53.13%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−726.27 K‬ USD

About GH Research PLC


Sector
Health Technology
CEO
Velichka Valcheva
Headquarters
Dublin
Website
ghres.com
Founded
2021
ISIN
IE000GID8VI0
FIGI
BBG011BQC379
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GHRS news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GHRS is 13.71 USD — it has increased by 1.55% in the past 24 hours. Watch GH Research PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GH Research PLC stocks are traded under the ticker GHRS.
GHRS stock has fallen by −29.55% compared to the previous week, the month change is a 61.58% rise, over the last year GH Research PLC has showed a 67.20% increase.
We've gathered analysts' opinions on GH Research PLC future price: according to them, GHRS price has a max estimate of 40.00 USD and a min estimate of 18.00 USD. Watch GHRS chart and read a more detailed GH Research PLC stock forecast: see what analysts think of GH Research PLC and suggest that you do with its stocks.
GHRS reached its all-time high on Nov 19, 2021 with the price of 30.43 USD, and its all-time low was 5.05 USD and was reached on Dec 18, 2023. View more price dynamics on GHRS chart.
See other stocks reaching their highest and lowest prices.
GHRS stock is 5.98% volatile and has beta coefficient of 0.62. Track GH Research PLC stock price on the chart and check out the list of the most volatile stocks — is GH Research PLC there?
Today GH Research PLC has the market capitalization of ‪721.89 M‬, it has decreased by −8.05% over the last week.
Yes, you can track GH Research PLC financials in yearly and quarterly reports right on TradingView.
GH Research PLC is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
GHRS earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.25 USD resulting in a 6.50% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about GH Research PLC earnings.
GH Research PLC revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
GHRS net income for the last quarter is ‪−12.11 M‬ USD, while the quarter before that showed ‪−10.38 M‬ USD of net income which accounts for −16.72% change. Track more GH Research PLC financial stats to get the full picture.
No, GHRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 11, 2025, the company has 49.00 employees. See our rating of the largest employees — is GH Research PLC on this list?
Like other stocks, GHRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GH Research PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GH Research PLC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GH Research PLC stock shows the strong buy signal. See more of GH Research PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.